Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

2.

T-DXd Reduces Residual Disease in Early Breast Cancer

3.

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

4.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

5.

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot